355 related articles for article (PubMed ID: 2134073)
1. Problems associated with medical therapy of canine hyperadrenocorticism.
Nichols R
Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
[TBL] [Abstract][Full Text] [Related]
2. [Formal pathogenesis, average age and breed distribution in the comparison of 61 Lysodren-treated and 36 untreated cases of canine hyperadrenocorticism which were dissected in the years 1975 to 1991 at the Institute for Veterinary Pathology of the Free University of Berlin].
Nothelfer HB; Weinhold K
Berl Munch Tierarztl Wochenschr; 1992 Sep; 105(9):305-11. PubMed ID: 1417721
[TBL] [Abstract][Full Text] [Related]
3. Hyperadrenocorticism: treating dogs.
Brown CG; Graves TK
Compend Contin Educ Vet; 2007 Mar; 29(3):132-4, 136, 138 passim; quiz 144-5. PubMed ID: 17726933
[TBL] [Abstract][Full Text] [Related]
4. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
Nelson RW; Feldman EC; Shinsako J
Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS; Farver TB
J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
[TBL] [Abstract][Full Text] [Related]
6. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
Feldman EC; Bruyette DS; Nelson RW; Farver TB
J Am Vet Med Assoc; 1990 Jul; 197(1):71-8. PubMed ID: 2370223
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
Behrend EN; Kemppainen RJ; Clark TP; Salman MD; Peterson ME
J Am Vet Med Assoc; 1999 Oct; 215(7):938-43. PubMed ID: 10511856
[No Abstract] [Full Text] [Related]
8. o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
Peterson ME
J Am Vet Med Assoc; 1983 Mar; 182(5):527-8. PubMed ID: 6300010
[No Abstract] [Full Text] [Related]
9. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
10. Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980-1984).
Scavelli TD; Peterson ME; Matthiesen DT
J Am Vet Med Assoc; 1986 Nov; 189(10):1360-4. PubMed ID: 3793588
[TBL] [Abstract][Full Text] [Related]
11. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
Ford SL; Feldman EC; Nelson RW
J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
[TBL] [Abstract][Full Text] [Related]
12. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
[TBL] [Abstract][Full Text] [Related]
13. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
Kintzer PP; Peterson ME
J Am Vet Med Assoc; 1994 Jul; 205(1):54-61. PubMed ID: 7928549
[TBL] [Abstract][Full Text] [Related]
14. Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment.
Peterson ME; Altszuler N
Am J Vet Res; 1981 Nov; 42(11):1881-3. PubMed ID: 7199880
[TBL] [Abstract][Full Text] [Related]
15. Use of ketoconazole to treat dogs with pituitary-dependent hyperadrenocorticism: 48 cases (1994-2007).
Lien YH; Huang HP
J Am Vet Med Assoc; 2008 Dec; 233(12):1896-901. PubMed ID: 19072605
[TBL] [Abstract][Full Text] [Related]
16. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
Angles JM; Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
[TBL] [Abstract][Full Text] [Related]
17. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.
Reine NJ
Clin Tech Small Anim Pract; 2007 Feb; 22(1):18-25. PubMed ID: 17542193
[TBL] [Abstract][Full Text] [Related]
18. Perianal adenomas and hypertestosteronemia in a spayed bitch with pituitary-dependent hyperadrenocorticism.
Dow SW; Olson PN; Rosychuk RA; Withrow SJ
J Am Vet Med Assoc; 1988 May; 192(10):1439-41. PubMed ID: 2839445
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).
Peterson ME
Vet Clin North Am Small Anim Pract; 2001 Sep; 31(5):1005-14, viii. PubMed ID: 11570123
[TBL] [Abstract][Full Text] [Related]
20. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986).
Nelson RW; Ihle SL; Feldman EC
J Am Vet Med Assoc; 1989 Jun; 194(11):1612-7. PubMed ID: 2753785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
